Sale!

FKTN Gene Cardiomyopathy dilated type 1X Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FKTN Gene Cardiomyopathy Dilated Type 1X Genetic Test is a specialized diagnostic tool used to identify mutations in the FKTN gene, which are linked to the development of dilated cardiomyopathy type 1X (DCM1X). This condition is a form of heart disease characterized by the enlargement and weakening of the heart’s main pumping chamber, leading to decreased heart function and potentially severe cardiac symptoms, including heart failure.

Performed at DNA Labs UAE, this genetic test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it for specific genetic alterations in the FKTN gene. The presence of these mutations can confirm the diagnosis of DCM1X, allowing for personalized treatment plans and management strategies to be developed for affected individuals.

The cost of the FKTN Gene Cardiomyopathy Dilated Type 1X Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the genetic variations associated with this condition, providing crucial information for patients and their families regarding the prognosis, potential treatment options, and the likelihood of passing the condition on to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FKTN Gene Cardiomyopathy dilated type 1X Genetic Test

At DNA Labs UAE, we offer the FKTN Gene Cardiomyopathy dilated type 1X Genetic Test for individuals who suspect or have been diagnosed with dilated cardiomyopathy. This genetic test focuses on detecting mutations or variations in the FKTN gene, which is associated with this specific type of cardiomyopathy.

Test Details

The FKTN gene cardiomyopathy, dilated type 1X is a type of genetic test that utilizes NGS (Next-Generation Sequencing) technology. NGS allows for the simultaneous analysis of multiple genes or regions of the genome, making it a highly efficient and accurate method for genetic testing.

In the context of cardiomyopathy, NGS can identify mutations or variations in the FKTN gene that may be responsible for the development of dilated cardiomyopathy. The FKTN gene encodes a protein called fukutin, which plays a crucial role in maintaining the structural integrity of muscle cells, including those in the heart. Mutations in the FKTN gene can lead to abnormal glycosylation of alpha-dystroglycan, resulting in the development of dilated cardiomyopathy.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Symptoms and Diagnosis

Dilated cardiomyopathy is characterized by the enlargement and weakening of the heart muscle. Individuals with suspected or confirmed dilated cardiomyopathy may experience symptoms such as shortness of breath, fatigue, irregular heartbeat, and swelling in the legs and ankles. Diagnosis of dilated cardiomyopathy involves a thorough clinical evaluation, including medical history, physical examination, and various diagnostic tests such as echocardiogram, electrocardiogram, and cardiac MRI.

Pre Test Information

Prior to undergoing the FKTN Gene Cardiomyopathy dilated type 1X NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by FKTN Gene Cardiomyopathy dilated type 1X NGS Genetic DNA Test gene FKTN. This information helps healthcare professionals understand the genetic inheritance pattern and assess the risk of developing dilated cardiomyopathy.

Test Benefits

The FKTN Gene Cardiomyopathy dilated type 1X NGS genetic test can be beneficial in several ways. It can aid in the diagnosis of individuals with suspected or confirmed dilated cardiomyopathy, providing valuable information for healthcare professionals to confirm the diagnosis, understand the underlying genetic cause, and guide treatment and management strategies. Additionally, the test can be used for carrier testing in individuals with a family history of the condition, helping them make informed decisions regarding their healthcare.

Conclusion

Genetic testing, such as the FKTN Gene Cardiomyopathy dilated type 1X NGS genetic test, plays a crucial role in the diagnosis and management of dilated cardiomyopathy. By identifying mutations or variations in the FKTN gene, healthcare professionals can gain insights into the genetic factors contributing to the development of this condition. At DNA Labs UAE, we offer this advanced genetic test at a cost of 4400.0 AED. Contact us today to schedule an appointment or learn more about our services.

Test Name FKTN Gene Cardiomyopathy dilated type 1X Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FKTN Gene Cardiomyopathy, dilated type 1X NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FKTN Gene Cardiomyopathy, dilated type 1X NGS Genetic DNA Test gene FKTN
Test Details

FKTN gene cardiomyopathy, dilated type 1X is a type of genetic test that focuses on detecting mutations or variations in the FKTN gene. This gene is associated with a specific type of cardiomyopathy called dilated cardiomyopathy, which is characterized by the enlargement and weakening of the heart muscle.

NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes or regions of the genome. In the context of genetic testing for cardiomyopathy, NGS can be used to identify mutations or variations in the FKTN gene, which may be responsible for the development of dilated cardiomyopathy.

The FKTN gene encodes a protein called fukutin, which is involved in the glycosylation of alpha-dystroglycan, a protein that plays a crucial role in maintaining the structural integrity of muscle cells, including those in the heart. Mutations in the FKTN gene can lead to abnormal glycosylation of alpha-dystroglycan, resulting in the development of dilated cardiomyopathy.

The FKTN gene cardiomyopathy, dilated type 1X NGS genetic test can help in the diagnosis of individuals with suspected or confirmed dilated cardiomyopathy. It can also be used for carrier testing in individuals with a family history of the condition. The test involves analyzing the DNA sample of the individual to identify any mutations or variations in the FKTN gene that may be contributing to the development of cardiomyopathy.

The results of the genetic test can provide valuable information for healthcare professionals in terms of confirming the diagnosis, understanding the underlying genetic cause, and guiding treatment and management strategies for affected individuals and their families. Genetic counseling is often recommended before and after undergoing genetic testing to help individuals understand the implications of the test results and make informed decisions regarding their healthcare.